Medicare Enrolled
Dr. Marc Hirsh, M.D.
Interventional Pain Medicine Physician · Delray Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hirsh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hirsh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hirsh
Dr. Marc Hirsh is an interventional pain medicine physician in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Hirsh performed 424,981 Medicare services across 15,329 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hirsh received a total of $12,876 from 43 pharmaceutical and/or device companies across 739 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hirsh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in FL$ $12,876 industry payments
Medicare Practice Summary
Medicare Utilization ↗424,981
Medicare services
Top 1% in FL for interventional pain medicine physician
15,329
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~22,367 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 232,000 | $4 | $21 |
| Tocilizumab injection (Actemra) | 39,840 | $5 | $14 |
| Abatacept infusion (Orencia) | 31,676 | $34 | $134 |
| Steroid injection (triamcinolone) | 23,515 | $1 | $4 |
| Romosozumab injection (Evenity) for osteoporosis | 22,890 | $8 | $24 |
| Golimumab infusion (Simponi Aria) | 19,250 | $11 | $59 |
| Denosumab injection (Prolia/Xgeva) | 18,780 | $18 | $53 |
| Office visit, established patient (30-39 min) | 3,708 | $100 | $338 |
| Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,164 | $30 | $157 |
| Methotrexate sodium, 5 mg | 3,108 | $0 | $1 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 2,892 | $59 | $232 |
| Infliximab infusion (Remicade) | 2,404 | $26 | $183 |
| Extended-release steroid injection (Zilretta) | 2,305 | $13 | $48 |
| Betamethasone steroid injection | 2,054 | $5 | $18 |
| Ultrasonic guidance for needle placement | 1,982 | $48 | $380 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 1,712 | $51 | $200 |
| Injection into tendon or ligament | 1,655 | $39 | $210 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 1,300 | $87 | $345 |
| Complete ultrasound scan of joint | 840 | $43 | $242 |
| X-ray of hand, minimum of 3 views | 819 | $31 | $96 |
| Administration of chemotherapy into vein, 1 hour or less | 780 | $108 | $479 |
| Blood draw (venipuncture) | 776 | $8 | $21 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 683 | $35 | $147 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 627 | $50 | $166 |
| New patient office visit (45-59 min) | 534 | $127 | $533 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 515 | $72 | $315 |
| X-ray of lower and sacral spine, 2-3 views | 452 | $33 | $105 |
| Shoulder X-ray, 2+ views | 358 | $28 | $91 |
| Hip X-ray, 2-3 views | 329 | $39 | $123 |
| Office visit, established patient (20-29 min) | 303 | $71 | $238 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 283 | $60 | $280 |
| Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | 252 | $37 | $440 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 252 | $39 | $141 |
| Drug injection, under skin or into muscle | 247 | $11 | $73 |
| Injection of additional new drug or substance into vein | 211 | $13 | $62 |
| Knee X-ray, 3 views | 189 | $33 | $107 |
| X-ray of knee, 1-2 views | 183 | $28 | $90 |
| Injection of trigger points, 1-2 muscles | 171 | $39 | $172 |
| X-ray of both hips, 3-4 views | 162 | $44 | $140 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 135 | $132 | $443 |
| Foot X-ray, 3+ views | 132 | $28 | $91 |
| Administration of chemotherapy into vein, each additional hour | 127 | $23 | $104 |
| X-ray of upper spine, 4-5 views | 116 | $44 | $139 |
| Injection, diphenhydramine hcl, up to 50 mg | 104 | $1 | $3 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 98 | $59 | $380 |
| X-ray of middle spine, 2 views | 95 | $26 | $86 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 88 | $4 | $17 |
| X-ray of both knees while standing | 87 | $33 | $106 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 84 | $58 | $342 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 82 | $405 | $3,048 |
| Comprehensive ultrasound scan of entire length of nerves in extremity | 71 | $60 | $300 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 66 | $18 | $66 |
| Joint injection, major joint | 63 | $66 | $309 |
| Injection of carpal tunnel | 48 | $78 | $277 |
| New patient office visit, complex (60-74 min) | 47 | $165 | $667 |
| X-ray of upper spine, 2-3 views | 45 | $33 | $104 |
| X-ray of elbow, 2 views | 43 | $24 | $77 |
| X-ray of pelvis, 1-2 views | 42 | $23 | $73 |
| X-ray of ankle, minimum of 3 views | 41 | $29 | $97 |
| Office visit, established patient, complex (40-54 min) | 32 | $146 | $474 |
| Injection of anesthetic agent and/or steroid into rib nerve | 28 | $80 | $528 |
| Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block | 27 | $28 | $770 |
| Injection, methylprednisolone acetate, 20 mg | 26 | $5 | $10 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 22 | $180 | $725 |
| X-ray of ankle, 2 views | 16 | $27 | $85 |
| Aspiration and/or injection of fluid from medium joint | 15 | $33 | $192 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.5% high complexity
83.6% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,876
Total received (2018-2024)
Avg $1,839/year across 7 years
Top 20% in FL for interventional pain medicine physician
43
Companies
739
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,642 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$234 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,533
2023$1,765
2022$2,163
2021$2,326
2020$1,158
2019$2,096
2018$1,834
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,084
UCB, Inc.
$1,564
Janssen Biotech, Inc.
$1,175
PFIZER INC.
$1,107
E.R. Squibb & Sons, L.L.C.
$1,049
Novartis Pharmaceuticals Corporation
$725
Radius Health, Inc.
$702
AstraZeneca Pharmaceuticals LP
$620
Janssen Scientific Affairs, LLC
$462
AbbVie Inc.
$403
AbbVie, Inc.
$386
ABBVIE INC.
$359
Genentech USA, Inc.
$333
GlaxoSmithKline, LLC.
$180
Mallinckrodt Hospital Products Inc.
$138
Lilly USA, LLC
$135
GENZYME CORPORATION
$133
Sobi, Inc
$128
SANOFI-AVENTIS U.S. LLC
$117
Celgene Corporation
$106
Horizon Therapeutics plc
$105
Orthogenrx Inc.
$92
DePuy Synthes Sales Inc.
$86
Pacira Pharmaceuticals Incorporated
$75
Takeda Pharmaceuticals U.S.A., Inc.
$64
SOBI, INC
$60
Pacira Therapeutics, Inc.
$57
Merck Sharp & Dohme Corporation
$53
Mallinckrodt Enterprises LLC
$45
Flexion Therapeutics, Inc.
$42
Organon Llc
$34
FIDIA PHARMA USA INC.
$34
Alexion Pharmaceuticals, Inc.
$27
Organon LLC
$26
ANI Pharmaceuticals, Inc.
$26
Horizon Pharma plc
$25
GRT US Holding, Inc.
$23
Bioventus LLC
$22
Zimmer Biomet Holdings, Inc.
$20
Mallinckrodt LLC
$16
Hikma Pharmaceuticals USA
$14
West-Ward Pharmaceuticals
$13
Endo Pharmaceuticals Inc.
$12
Top 3 companies account for 37.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · Exparel · FORTEO · GPS III PLATELET CONCENTRATION SYSTEM · GenVisc 850 · HADLIMA · HUMIRA · HYALGAN · Humira · ILARIS · INFLECTRA · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LYRICA · MONOVISC · Mitigare · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · Supartz FX Sodium Hyaluronate · TALTZ · TREMFYA · Tymlos · Uloric · XELJANZ · XIAFLEX · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
35
Per 100K population
2.3
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hirsh is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 20%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hirsh experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hirsh performed 232,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hirsh receive payments from pharmaceutical companies?
Yes. Dr. Hirsh received a total of $12,876 from 43 companies across 739 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hirsh's costs compare to other interventional pain medicine physicians in Delray Beach?
Dr. Hirsh's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hirsh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Delray Beach
Browse interventional pain medicine physicians in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in FL
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in FL
Which FL interventional pain medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology